Recordati Investor Relations Material
Latest events
Q1 2025
Recordati
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Recordati Industria Chimica e Farmaceutica S.p.A.
Access all reports
Recordati Industria Chimica e Farmaceutica S.p.A., engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. It operates through three segments: Ethical Division, Orphan Drugs Division, and Others. The Ethical Division offers a range of branded prescription products active in therapeutic areas comprising products for cardiovascular system disorders; respiratory system diseases; digestive and metabolism therapies; anti-infectives; hormones and synthetic substitutes; central nervous system disorders; and oncology drugs.The Orphan Drugs Division offers Cerliponase Alfa for treatment of neuronal ceroid lipofuscinoses type 2 (CLN2), a neurodegenerative disease; Laronidase for treatment of mucopolysaccharidosis I, an enzyme deficiency that causes progressive damage to various parts of body.
Key slides for Recordati Industria Chimica e Farmaceutica S.p.A.
Q4 2024
Recordati Industria Chimica e Farmaceutica S.p.A.
Investor Update
Recordati Industria Chimica e Farmaceutica S.p.A.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
REC
Country
🇮🇹 Italy